Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...
With an expiration date still more than a year away, here's what the latest details reveal.
These 4 big technology bets will reshape the global economy in 2026 ...
Here's how your social life could affect your dementia risk.
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Corewell Health has big plans for its Butterworth Hospital campus in Grand Rapids.
On April 17th, our Board declared a cash dividend of $0.20 per share on the company's voting common stock, expected to be ...
In a multicenter, phase 2 trial across 31 centers in 10 countries, apecotrep (BI 764198) reduced proteinuria by 40% over 12 ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
WD-40 Company (NASDAQ:WDFC) Q1 2026 Earnings Call Transcript January 8, 2026 WD-40 Company misses on earnings expectations.
When making a Dungeons and Dragons character, few decisions are as important as the class. Furthermore, players must consider what level the campaign is reaching, as any given class is going to ...